Long term, prospective, observational cohort study evaluating the safety profile in patients with highly active relapsing multiple sclerosis (RMS) newly started on oral cladribine – CLARION

Project: Research

Project Details

StatusActive
Effective start/end date23/11/2331/08/34

Funding

  • IQVIA (Finland)

Keywords

  • clinical trial
  • MSBase
  • multiple sclerosis
  • cladribine